We examined GSNOR protein levels in various lung cancer tissues by immunohistochemistry using the above described three GSNOR-specific monoclonal antibodies and compared the tissue staining pattern to the commercially available polyclonal antibody used in a previous publication [12]. This evidence concerns the gene ADH5 and lung carcinoma.